Conformal and Intensity-modulated Radiotherapy for Cervical Cancer

Clinical Oncology

Volumn 20, Issue 6, 2008, Pages 417-425

  Taylor, A ^a   Powell, M E B ^b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Cervical cancer; cervix cancer; conformal radiotherapy; IMRT; radiotherapy; target volume

Indexed keywords

ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; DOSIMETRY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; OUTCOME ASSESSMENT; PATIENT POSITIONING; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT PLANNING; UTERINE CERVIX CANCER;

BRACHYTHERAPY; FEMALE; HUMANS; RADIOMETRY; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 46149110477     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2008.04.004     Document Type: Article

References (75)

1. Green J.A., Kirwan J.M., Tierney J.F., et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 358 (2001) 781-786
2. Snijders-Keilholz A., van Acht M., de Vroome H., et al. Pelvic failure rate and radiation toxicity in relation to total dose of radiation alone for the treatment of cancer of the uterine cervix. Clin Oncol (R Coll Radiol) 5 (1993) 6-10
3. Perez C.A., Kuske R.R., Camel H.M., et al. Analysis of pelvic tumor control and impact on survival in carcinoma of the uterine cervix treated with radiation therapy alone. Int J Radiat Oncol Biol Phys 14 (1988) 613-621
4. Ferrigno R., dos Santos Novaes P.E., Pellizzon A.C., et al. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications. Int J Radiat Oncol Biol Phys 50 (2001) 1123-1135
5. Roeske J.C., Mundt A.J., Halpern H., et al. Late rectal sequelae following definitive radiation therapy for carcinoma of the uterine cervix: a dosimetric analysis. Int J Radiat Oncol Biol Phys 37 (1997) 351-358
6. Gallagher M.J., Brereton H.D., Rostock R.A., et al. A prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation. Int J Radiat Oncol Biol Phys 12 (1986) 1565-1573
7. Perez C.A., Grigsby P.W., Chao K.S., et al. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix. Int J Radiat Oncol Biol Phys 41 (1998) 307-317
8. Bonin S.R., Lanciano R.M., Corn B.W., et al. Bony landmarks are not an adequate substitute for lymphangiography in defining pelvic lymph node location for the treatment of cervical cancer with radiotherapy. Int J Radiat Oncol Biol Phys 34 (1996) 167-172
9. Greer B.E., Koh W.J., Figge D.C., et al. Gynecologic radiotherapy fields defined by intraoperative measurements. Gynecol Oncol 38 (1990) 421-424
10. McAlpine J., Schlaerth J.B., Lim P., et al. Radiation fields in gynecologic oncology: correlation of soft tissue (surgical) to radiologic landmarks. Gynecol Oncol 92 (2004) 25-30
11. Pendlebury S.C., Cahill S., Crandon A.J., et al. Role of bipedal lymphangiogram in radiation treatment planning for cervix cancer. Int J Radiat Oncol Biol Phys 27 (1993) 959-962
12. Zunino S., Rosato O., Lucino S., et al. Anatomic study of the pelvis in carcinoma of the uterine cervix as related to the box technique. Int J Radiat Oncol Biol Phys 44 (1999) 53-59
13. Kim R.Y., McGinnis L.S., Spencer S.A., et al. Conventional four-field pelvic radiotherapy technique without computed tomography - treatment planning in cancer of the cervix: potential geographic miss and its impact on pelvic control. Int J Radiat Oncol Biol Phys 31 (1995) 109-112
14. Russell A.H., Walter J.P., Anderson M.W., et al. Sagittal magnetic resonance imaging in the design of lateral radiation treatment portals for patients with locally advanced squamous cancer of the cervix. Int J Radiat Oncol Biol Phys 23 (1992) 449-455
15. Weiss E., Eberlein K., Pradier O., et al. The impact of patient positioning on the adequate coverage of the uterus in the primary irradiation of cervical carcinoma: a prospective analysis using magnetic resonance imaging. Radiother Oncol 63 (2002) 83-87
16. Thomas L., Chacon B., Kind M., et al. Magnetic resonance imaging in the treatment planning of radiation therapy in carcinoma of the cervix treated with the four-field pelvic technique. Int J Radiat Oncol Biol Phys 37 (1997) 827-832
17. Mayr N.A., Tali E.T., Yuh W.T., et al. Cervical cancer: application of MR imaging in radiation therapy. Radiology 189 (1993) 601-608
18. Gerstner N., Wachter S., Knocke T.H., et al. The benefit of beam's eye view based 3D treatment planning for cervical cancer. Radiother Oncol 51 (1999) 71-78
19. Bridgewater C.H., Taylor A., and Powell M.E.B. Whole pelvic radiotherapy: are we missing tumour? A UK survey of current practice in cervix cancer. Clin Oncol 17 Suppl. 1 (2005) P3.4
20. International Commission on Radiation Units and Measurements. Prescribing, recording and reporting photon beam therapy (1993), International Commission on Radiation Units and Measurements, Bethesda
21. International Commission on Radiation Units and Measurements. Prescribing, recording and reporting photon beam therapy (supplement to CRU report 50) (1999), International Commission on Radiation Units and Measurements, Bethesda
22. Hricak H., Lacey C.G., Sandles L.G., et al. Invasive cervical carcinoma: comparison of MR imaging and surgical findings. Radiology 166 (1988) 623-631
23. Greco A., Mason P., Leung A.W., et al. Staging of carcinoma of the uterine cervix: MRI-surgical correlation. Clin Radiol 40 (1989) 401-405
24. Bipat S., Glas A.S., van der Velden J., et al. Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. Gynecol Oncol 91 (2003) 59-66
25. Scheidler J., Hricak H., Yu K.K., et al. Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. JAMA 278 (1997) 1096-1101
26. Williams A.D., Cousins C., Soutter W.P., et al. Detection of pelvic lymph node metastases in gynecologic malignancy: a comparison of CT, MR imaging, and positron emission tomography. AJR Am J Roentgenol 177 (2001) 343-348
27. Henriksen E. The lymphatic spread of carcinoma of the cervix and of the body of the uterus; a study of 420 necropsies. Am J Obstet Gynecol 58 (1949) 924-942
28. Reiffenstuhl G. The lymphatics of the female genital organs (1964), Lippincott, Philadelphia
29. Benedetti-Panici P., Maneschi F., Scambia G., et al. Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol 62 (1996) 19-24
30. Chao K.S., and Lin M. Lymphangiogram-assisted lymph node target delineation for patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 54 (2002) 1147-1152
31. Taylor A., Rockall A.G., Reznek R.H., et al. Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 63 (2005) 1604-1612
32. Taylor A., Rockall A.G., and Powell M.E. An atlas of the pelvic lymph node regions to aid radiotherapy target volume definition. Clin Oncol (R Coll Radiol) 19 (2007) 542-550
33. Buchali A., Koswig S., Dinges S., et al. Impact of the filling status of the bladder and rectum on their integral dose distribution and the movement of the uterus in the treatment planning of gynaecological cancer. Radiother Oncol 52 (1999) 29-34
34. Kaatee R.S., Olofsen M.J., Verstraate M.B., et al. Detection of organ movement in cervix cancer patients using a fluoroscopic electronic portal imaging device and radiopaque markers. Int J Radiat Oncol Biol Phys 54 (2002) 576-583
35. Huh S.J., Park W., and Han Y. Interfractional variation in position of the uterus during radical radiotherapy for cervical cancer. Radiother Oncol 71 (2004) 73-79
36. van de Bunt L., van der Heide U.A., Ketelaars M., et al. Conventional, conformal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: the impact of tumor regression. Int J Radiat Oncol Biol Phys 64 (2006) 189-196
37. Mock U., Dieckmann K., Wolff U., et al. Portal imaging based definition of the planning target volume during pelvic irradiation for gynecological malignancies. Int J Radiat Oncol Biol Phys 45 (1999) 227-232
38. Stroom J.C., Olofsen-van Acht M.J., Quint S., et al. On-line set-up corrections during radiotherapy of patients with gynecologic tumors. Int J Radiat Oncol Biol Phys 46 (2000) 499-506
39. Creutzberg C.L., Althof V.G., de Hoog M.D., et al. A quality control study of the accuracy of patient positioning in irradiation of pelvic fields. Int J Radiat Oncol Biol Phys 34 (1996) 697-708
40. Han Y., Shin E.H., Huh S.J., et al. Interfractional dose variation during intensity-modulated radiation therapy for cervical cancer assessed by weekly CT evaluation. Int J Radiat Oncol Biol Phys 65 (2006) 617-623
41. Taylor A., and Powell M.E.B. Dose escalation with simultaneous integrated boost intensity-modulated radiotherapy for cervical cancer - impact of interfractional organ motion. Eur J Cancer 5 (2007) 122
42. Roeske J.C., Lujan A., Rotmensch J., et al. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 48 (2000) 1613-1621
43. Nutting C.M., Convery D.J., Cosgrove V.P., et al. Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer. Int J Radiat Oncol Biol Phys 48 (2000) 649-656
44. Georg P., Georg D., Hillbrand M., et al. Factors influencing bowel sparing in intensity modulated whole pelvic radiotherapy for gynaecological malignancies. Radiother Oncol 80 (2006) 19-26
45. Mundt A.J., Lujan A.E., Rotmensch J., et al. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 52 (2002) 1330-1337
46. Nutting C.M., Corbishley C.M., Sanchez-Nieto B., et al. Potential improvements in the therapeutic ratio of prostate cancer irradiation: dose escalation of pathologically identified tumour nodules using intensity modulated radiotherapy. Br J Radiol 75 (2002) 151-161
47. Das I.J., Lanciano R.M., Movsas B., et al. Efficacy of a belly board device with CT-simulation in reducing small bowel volume within pelvic irradiation fields. Int J Radiat Oncol Biol Phys 39 (1997) 67-76
48. Fu Y.T., Lam J.C., and Tze J.M. Measurement of irradiated small bowel volume in pelvic irradiation and the effect of a bellyboard. Clin Oncol (R Coll Radiol) 7 (1995) 188-192
49. Koelbl O., Richter S., and Flentje M. Influence of patient positioning on dose-volume histogram and normal tissue complication probability for small bowel and bladder in patients receiving pelvic irradiation: a prospective study using a 3D planning system and a radiobiological model. Int J Radiat Oncol Biol Phys 45 (1999) 1193-1198
50. Olofsen-van Acht M., van den Berg H., Quint S., et al. Reduction of irradiated small bowel volume and accurate patient positioning by use of a bellyboard device in pelvic radiotherapy of gynecological cancer patients. Radiother Oncol 59 (2001) 87-93
51. Adli M., Mayr N.A., Kaiser H.S., et al. Does prone positioning reduce small bowel dose in pelvic radiation with intensity-modulated radiotherapy for gynecologic cancer?. Int J Radiat Oncol Biol Phys 57 (2003) 230-238
52. Greven K.M., Lanciano R.M., Herbert S.H., et al. Analysis of complications in patients with endometrial carcinoma receiving adjuvant irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 919-923
53. Yamazaki A., Shirato H., Nishioka T., et al. Reduction of late complications after irregularly shaped four-field whole pelvic radiotherapy using computed tomographic simulation compared with parallel-opposed whole pelvic radiotherapy. Jpn J Clin Oncol 30 (2000) 180-184
54. Mundt A.J., Roeske J.C., Lujan A.E., et al. Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies. Gynecol Oncol 82 (2001) 456-463
55. Mundt A.J., Mell L.K., and Roeske J.C. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys 56 (2003) 1354-1360
56. Roeske J.C., Bonta D., Mell L.K., et al. A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy. Radiother Oncol 69 (2003) 201-207
57. Brixey C.J., Roeske J.C., Lujan A.E., et al. Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 54 (2002) 1388-1396
58. Lujan A.E., Mundt A.J., Yamada S.D., et al. Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy. Int J Radiat Oncol Biol Phys 57 (2003) 516-521
59. Dogan N., King S., Emami B., et al. Assessment of different IMRT boost delivery methods on target coverage and normal-tissue sparing. Int J Radiat Oncol Biol Phys 57 (2003) 1480-1491
60. Chao K.S., Bosch W.R., Mutic S., et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 49 (2001) 1171-1182
61. Grosu A.L., Souvatzoglou M., Roper B., et al. Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer. Int J Radiat Oncol Biol Phys 69 (2007) 541-551
62. Malhotra H.K., Avadhani J.S., deBoer S.F., et al. Duplicating a tandem and ovoids distribution with intensity-modulated radiotherapy: a feasibility study. J Appl Clin Med Phys 8 (2007) 2450
63. Schefter T.E., Kavanagh B.D., Wu Q., et al. Technical considerations in the application of intensity-modulated radiotherapy as a concomitant integrated boost for locally-advanced cervix cancer. Med Dosim 27 (2002) 177-184
64. Gebara W.J., Weeks K.J., Jones E.L., et al. Carcinoma of the uterine cervix: a 3D - CT analysis of dose to the internal, external and common iliac nodes in tandem and ovoid applications. Radiother Oncol 56 (2000) 43-48
65. Terahara A., Nakano T., Ishikawa A., et al. Dose-volume histogram analysis of high dose rate intracavitary brachytherapy for uterine cervix cancer. Int J Radiat Oncol Biol Phys 35 (1996) 549-554
66. Ito H., Kutuki S., Nishiguchi I., et al. Radiotherapy for cervical cancer with high-dose rate brachytherapy correlation between tumor size, dose and failure. Radiother Oncol 31 (1994) 240-247
67. Chan P., Yeo I., Perkins G., et al. Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study. Radiat Oncol 1 (2006) 13
68. Guerrero M., Li X.A., Ma L., et al. Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: radiobiological and dosimetric considerations. Int J Radiat Oncol Biol Phys 62 (2005) 933-939
69. Kavanagh B.D., Schefter T.E., Wu Q., et al. Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer. Semin Radiat Oncol 12 (2002) 260-271
70. D'Souza W.D., Ahamad A.A., Iyer R.B., et al. Feasibility of dose escalation using intensity-modulated radiotherapy in posthysterectomy cervical carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 1062-1070
71. Portelance L., Chao K.S., Grigsby P.W., et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys 51 (2001) 261-266
72. Beriwal S., Gan G.N., Heron D.E., et al. Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 68 (2007) 166-171
73. Salama J.K., Mundt A.J., Roeske J., et al. Preliminary outcome and toxicity report of extended-field, intensity-modulated radiation therapy for gynecologic malignancies. Int J Radiat Oncol Biol Phys 65 (2006) 1170-1176
74. Esthappan J., Mutic S., Malyapa R.S., et al. Treatment planning guidelines regarding the use of CT/PET-guided IMRT for cervical carcinoma with positive paraaortic lymph nodes. Int J Radiat Oncol Biol Phys 58 (2004) 1289-1297
75. Gerszten K., Colonello K., Heron D.E., et al. Feasibility of concurrent cisplatin and extended field radiation therapy (EFRT) using intensity-modulated radiotherapy (IMRT) for carcinoma of the cervix. Gynecol Oncol 102 (2006) 182-188